150
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Risk factors for HR- and HER2-defined breast cancer in Slovenian postmenopausal women

, , , &
Pages 68-74 | Received 05 May 2011, Accepted 25 Jul 2011, Published online: 01 Dec 2011

References

  • Garcia-Closas M, Brinton LA, Lissowska J, . Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 2006;95:123–9
  • Perou CM, Sorlie T, Eisen MB, . Molecular portraits of human breast tumours. Nature 2000;406:747–52
  • Sørlie T, Perou CM, Tibshirani R, . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869–74
  • Sørlie T, Tibshirani R, Parker J, . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418–23
  • Prat A, Parker JS, Karginova O, . Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010;12:R68
  • Carey LA. Through a glass darkly: advances in understanding breast cancer biology, 2000–2010. Clin Breast Cancer 2010;10:188–95
  • Rosenberg LU, Einarsdottir K, Friman EI, . Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:2482–8
  • Yang XR, Sherman ME, Rimm DL, . Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16: 439–43
  • Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218–28
  • Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 2003;12:1053–60
  • Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151:703–14
  • Rusiecki JA, Holford TR, Zahm SH, Zheng T. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev 2005;29:419–26
  • Ma H, Wang Y, Sullivan-Halley J, . Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 2010;70:575–87
  • Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER2-overexpressing, and triple-negative breast cancer. Cancer 2008; 113:1521–6
  • Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558–68
  • Yang XR, Chang-Claude J, Goode EL, . Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2001;103:250–63
  • Cerne JZ, Ferk P, Leskosek B, Gersak K. Hormone replacement therapy and some breast cancer risk factors among Slovenian postmenopausal women. Climacteric 2011;14:458–63
  • Leskosek B. A clinical research information system: two years experience of prospective observational study in oncology. AMIA Annual Symposium Proceedings 2009:930
  • Leskosek BL, Dimec J, Gersak K, Ferk P. A research information system (RIS) for breast cancer genetics. In Panagiotis BD, Pallikarakis N, eds. MEDICON 2010. IFMBE Proceedings of the 12th Mediterranean Conference on Medical and Biological Engineering and Computing. Heidelberg: Springer, May 27–30, 2010, Chalkidiki, 2010:851–4
  • Kaplowitz PB. Link between body fat and the timing of puberty. Pediatrics 2008;121:S208–17
  • , Lacey JV JrKreimer AR, Buys SS, . Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer 2009;9:84
  • Finley C, Gregg EV, Solomon LJ, . Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Commun Health 2001;26:39–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.